Haleon Plc Form 6-K Summary
Business Context and Reporting Period
This Form 6-K filing by Haleon Plc, a global leader in consumer health, covers the month of May 2025. The report specifically details a transaction in the company's own shares executed under its share buyback programme announced on March 28, 2025.
Key Financial Metrics and Share Capital
The filing does not provide revenue, profit, cash flow, margin, debt, or liquidity metrics. It focuses exclusively on share repurchase activity and capital structure updates.
- Shares Purchased: 825,666 ordinary shares
- Purchase Date: May 16, 2025
- Price Range: 401.70p (Low) to 406.30p (High)
- Volume Weighted Average Price: 404.03p
- Post-Transaction Registered Capital: 9,012,587,392 ordinary shares
- Treasury Shares Held: 4,080,205
- Voting Shares Outstanding: 9,008,507,187
Material Changes
The primary material change is the reduction of the company's share count due to the cancellation of 825,666 shares purchased on May 16, 2025. This transaction reduces the number of ordinary shares with voting rights to 9,008,507,187.
Guidance, Outlook, and Risks
The filing contains no forward-looking guidance, management commentary on financial performance, or discussion of risks and contingencies. It is a regulatory disclosure of a specific share transaction in compliance with the Market Abuse Regulation (Article 5(1)(b)).
Investor Verification Checklist
- Verify the total number of shares purchased under the buyback programme since its inception on March 28, 2025.
- Confirm the remaining authorization limit for the current buyback programme.
- Review the full trade breakdown available via the London Stock Exchange link provided in the filing.
- Check subsequent filings for updates to the treasury share count and voting rights.